Creative Planning
BIOC

Creative Planning’s Biocept, Inc. BIOC Stock Holding History

Creative Planning’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-393
Closed -$60K – 2687
2021
Q1 		$60K Hold
393
– – ﹤0.01% 2332
2020
Q4 		$52K Buy
393
+47
+14% +$6.7K ﹤0.01% 2097
2020
Q3 		$46K Hold
346
– – ﹤0.01% 1911
2020
Q2 		$74K Hold
346
– – ﹤0.01% 1715
2020
Q1 		$27K Hold
346
– – ﹤0.01% 1704
2019
Q4 		$30K Buy
+346
New +$59.7K ﹤0.01% 1851
2018
Q3 		– Sell
-59
Closed -$105K – 2193
2018
Q2 		$105K Buy
59
+1
+2% +$2.02K ﹤0.01% 1766
2018
Q1 		$153K Hold
58
– – ﹤0.01% 1672
2017
Q4 		$361K Buy
58
+1
+2% +$7.91K ﹤0.01% 1262
2017
Q3 		$628K Buy
57
+30
+111% +$355K ﹤0.01% 941
2017
Q2 		$338K Buy
+27
New +$382K ﹤0.01% 1216
2017
Q1 		– Hold
0
– – – 4533
2016
Q4 		– Sell
-1
Closed -$8.36K – 4912
2016
Q3 		$8K Sell
1
-5
-83% -$81.6K ﹤0.01% 3675
2016
Q2 		$115K Buy
6
+4
+200% +$96.8K ﹤0.01% 1585
2016
Q1 		$73K Hold
2
– – ﹤0.01% 1830
2015
Q4 		$78K Sell
2
-1
-33% -$53.1K ﹤0.01% 1790
2015
Q3 		$199K Buy
+3
New +$188K ﹤0.01% 1198
2015
Q2 		– Hold
0
– -$2K – 3247
2015
Q1 		– Hold
0
– – – 3928

Other funds holding BIOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
HSA
Hussman Strategic Advisors Ellicott City, Maryland $434M AUM 19.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Creative Planning's BIOC Position: Q2 2021 in Review

Creative Planning sold out of Biocept, Inc. (BIOC) in Q2 2021, closing a stake of 393 shares — an estimated $60K sold.

Creative Planning first reported a position in BIOC in Q3 2015 and held it in 16 quarters. The position peaked at $628K in Q3 2017. 21 funds tracked by Wall St. Rank hold BIOC as of Q2 2021.

  • Creative Planning reported no remaining Biocept, Inc. position as of Q2 2021 after selling out during the quarter.
  • Creative Planning sold 393 Biocept, Inc. shares in Q2 2021, an estimated $60K.
  • Creative Planning first reported a position in Biocept, Inc. in Q3 2015 and held it in 16 quarters.
  • Creative Planning's Biocept, Inc. position peaked at $628K in Q3 2017.
  • 21 funds tracked by Wall St. Rank held Biocept, Inc. as of Q2 2021.

Based on Creative Planning's 13F filing for Q2 2021, filed 4 Aug 2021.